Iovance Biotherapeutics, Inc.
$3.69B- Market cap
- $3.98B
- Debt
- +$1.00M
- Cash
- −$296.98M
Capital structure 100% equity / 0% debt · EV / Revenue 13.99x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
IOVA · current priceP/S 15.11x
$8.79Latest market snapshot
Implied fair value · at LUV's multiple
$0.4095.4% below market
0.58 IOVA revenue / share×0.69x LUV P/S=$0.40
Market $8.79Implied $0.40
LUV · current priceP/S 0.69x
$39.62Latest market snapshot
Implied fair value · at IOVA's multiple
$866.792,087.8% above market
57.36 LUV revenue / share×15.11x IOVA P/S=$866.79
Market $39.62Implied $866.79